A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

Clinical trial NCT06771245 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06771245
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Mild-to-moderate Essential Hypertension

Start date: 2025-01-24
Primary completion: 2026-03-30
Enrollment: 606

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.